GREAT BASIN SCIENTIFIC INC (GBSN) financial statements (2021 and earlier)
Company profile
| Business Address |
420 E. SOUTH TEMPLE SALT LAKE CITY, UT 84111 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 1 | 5 | 2 | ||
| Cash and cash equivalents | 1 | 5 | 2 | ||
| Receivables | 0 | 0 | 0 | ||
| Inventory, net of allowances, customer advances and progress billings | 1 | 1 | 0 | ||
| Inventory | 1 | 1 | 0 | ||
| Deferred costs | 0 | 0 | |||
| Other undisclosed current assets | 48 | 14 | 0 | ||
| Total current assets: | 51 | 21 | 3 | ||
| Noncurrent Assets | |||||
| Property, plant and equipment | 10 | 8 | 4 | ||
| Intangible assets, net (including goodwill) | 0 | 0 | 1 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 1 | ||
| Restricted cash and investments | 12 | ||||
| Other undisclosed noncurrent assets | (0) | ||||
| Total noncurrent assets: | 22 | 8 | 4 | ||
| TOTAL ASSETS: | 73 | 29 | 8 | ||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 4 | 2 | ||
| Accounts payable | 4 | 2 | 1 | ||
| Accrued liabilities | 6 | 1 | 1 | ||
| Employee-related liabilities | 0 | ||||
| Taxes payable | 0 | ||||
| Debt | 61 | 1 | 1 | ||
| Due to related parties | 1 | 1 | 0 | ||
| Other undisclosed current liabilities | 2 | (0) | |||
| Total current liabilities: | 71 | 7 | 3 | ||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 15 | 1 | 2 | ||
| Long-term debt, excluding current maturities | 15 | 1 | 0 | ||
| Capital lease obligations | 0 | 1 | 2 | ||
| Liabilities, other than long-term debt | 43 | 43 | 10 | ||
| Financial instruments subject to mandatory redemption, settlement terms, share value, amount | 6 | ||||
| Other liabilities | 1 | ||||
| Derivative instruments and hedges, liabilities | 36 | 43 | 10 | ||
| Total noncurrent liabilities: | 58 | 45 | 12 | ||
| Total liabilities: | 129 | 52 | 16 | ||
| Stockholders' equity | |||||
| Stockholders' equity attributable to parent | (56) | (23) | (8) | ||
| Preferred stock | 0 | 0 | |||
| Common stock | 0 | 0 | 0 | ||
| Additional paid in capital | 155 | 99 | 56 | ||
| Accumulated deficit | (211) | (122) | (64) | ||
| Total stockholders' equity: | (56) | (23) | (8) | ||
| TOTAL LIABILITIES AND EQUITY: | 73 | 29 | 8 | ||
Income statement (P&L) ($ in millions)
| 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|
| Revenues | 3 | 2 | 2 | |
| Cost of revenue | (8) | (5) | (4) | |
| Gross profit: | (5) | (3) | (2) | |
| Operating expenses | (29) | (20) | (10) | |
| Operating loss: | (34) | (22) | (12) | |
| Nonoperating expense | (55) | (35) | (10) | |
| Interest and debt expense | (24) | (12) | (1) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 24 | 12 | 1 | |
| Loss from continuing operations before income taxes: | (89) | (58) | (22) | |
| Income tax expense | (0) | (0) | (0) | |
| Net loss available to common stockholders, diluted: | (89) | (58) | (22) | |
Comprehensive Income ($ in millions)
| 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|
| Net loss: | (89) | (58) | (22) | |
| Comprehensive loss, net of tax, attributable to parent: | (89) | (58) | (22) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.